Sat.Apr 03, 2021 - Fri.Apr 09, 2021

article thumbnail

Sanofi buys an mRNA startup in another bet on 'off-the-shelf' cell therapy

Bio Pharma Dive

Tidal Therapeutics is the second biotech developing more convenient cell therapies that the French pharma has recently acquired, part of a broader expansion in oncology.

article thumbnail

Social media and prescription drugs: A study

World of DTC Marketing

QUICK READ: A two-month analysis of social media and prescription drugs found the number one reason online health seekers use social media is to share and ask questions about medication side effects. I also found an abundance of medication misinformation based on personal experiences and hearsay. In conjunction with leading consumer magazine I worked on a study to determine why people were using social media for information on prescription drugs and to examine and quantify what they were sharing

Drugs 294
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

In the News: March 2021 Regulatory and Development Updates

Camargo

Each month, Camargo’s “In the News” series highlights important changes and advancements in the regulatory and development space and explores how those changes could impact your program. Rare Disease Clinical Trials Most Often Terminated Due to Regulatory and Recruitment Issues. The difficulty associated with successfully completing rare disease clinical trials is well-known.

article thumbnail

Human trials for world's first AI-designed immuno-oncology drug

Pharma Times

The drug was discovered through an AI-design platform within just eight months of project initiation

Drugs 143
article thumbnail

Bridging Innovation & Patient Care: The Growing Role of AI

Speaker: Simran Kaur, Co-founder & CEO at Tattva Health Inc.

AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!

article thumbnail

Researchers lay out hypothesis for rare side effect linked to AstraZeneca vaccine

Bio Pharma Dive

The EMA has reiterated the benefits of the shot outweigh the risks, but the safety concerns are another hurdle to the vaccine's rollout in Europe.

article thumbnail

Healthcare is about profits, not patients

World of DTC Marketing

QUICK READ: The nation’s largest for-profit hospital chains saw higher profits , and some more than tripled their net income compared to last year. Some are also increasing their profit margins by forcing out healthcare staff who have seniority and earn more. As bigger corporations acquire smaller hospitals, this trend is accelerating. Maria has been an ER nurse in Southern California for almost 22 years.

Nurses 188

More Trending

article thumbnail

Is disability the last bastion of the representation debate?

pharmaphorum

From #MeToo to Black Lives Matter, as a society we have been discussing the relationship between representation and equality more than ever over the last few years. . But while progress is being made in so many areas, people with disabilities are still struggling to find a voice above the accepted narrative, says Ross Lannon, the 27-year-old blogger and multi-media content creator behind A Life on Wheels.

article thumbnail

New CAR-T therapy from Bristol, Bluebird effective but too costly, ICER finds

Bio Pharma Dive

The influential drug cost watchdog recommended a discount of between 37% and 54% to the $419,500 list price the companies charge for Abecma, a multiple myeloma cell therapy cleared by the FDA in March.

Drugs 311
article thumbnail

What do future healthcare CEOs look like?

World of DTC Marketing

QUICK READ: The compensation for pharma CEOs is starting to be reported and it’s off the charts. Bob Bradway of Amgen bagged a $20.1 million compensation package in 2020, a slight increase from his $19.6 million total the previous year. Pfizer CEO Bourla’s Pay Climbed 17% to $21 Million in 2020 and Gilead Sciences CEO Daniel O’Day earned a $19 million take home.

Vaccine 162
article thumbnail

Thousands to benefit from five-minute breast cancer treatment

Pharma Times

NHS England is rolling out Roche's new combined treatment Phesgo, which drastically cuts administration time

130
130
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

A Guide to Isolation Gown Selection

Pharma Mirror

Isolation gowns are essential equipment for infection-control strategies. They are the second most used PPE items after gloves. They were originally designed for health workers but can also be worn by random people to protect them from infections when they come in contact with infected people or substances. The different types of isolation gowns There are two major types of isolation gowns made for healthcare purposes: Surgical gowns: A surgical gown is a personal protective garment that is used

130
130
article thumbnail

With new data, Merck could be first to bring immunotherapy to early kidney cancer

Bio Pharma Dive

Keytruda has become the first drug of its kind to succeed in the so-called adjuvant setting in renal cell carcinoma, continuing an industry-wide push to establish immunotherapy in earlier lines of cancer care.

Drugs 302
article thumbnail

Digital tool will be tested against COVID-19 ‘brain fog’

pharmaphorum

A digital tool used to treat attention-deficit hyperactivity disorder (ADHD) is being tested to see if it can help counter lingering, fuzzy thinking in COVID-19 survivors, a condition sometimes known as ‘brain fog’ An app called EndeavorRx – developed by PureTech Health-backed Akili Interactive – will be tested in two clinical trials to see if it can improve cognitive function in people who have recovered from COVID-19 but still show cognitive problems weeks or months later.

article thumbnail

Molecules from Probiotic-Rich Foods May Combat “Cytokine Storm” in COVID-19

BioSpace

A recent study from Ben-Gurion University of the Negev (BGU) found that isolated molecules from probiotic-rich dairy products could have potential as novel drug candidates for fighting against pathogenic bacteria and treating inflammatory diseases.

Bacteria 123
article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

NICE 'no' for Opdivo/Yervoy lung cancer combo

Pharma Times

The combination is not considered to be a cost-effective use of NHS resources in this setting

123
123
article thumbnail

Biogen adds a late-stage prospect to its growing biosimilar business

Bio Pharma Dive

A deal with Bio-Thera Solutions hands Biogen rights to a late-stage copycat of Actemra, Roche's blockbuster treatment for inflammatory diseases.

296
296
article thumbnail

The next generation of immunotherapy? Innate Pharma targets NK cells

pharmaphorum

Clinical-stage oncology biotech Innate Pharma is on a mission to harness the power of natural killer cells to fight cancer. Catherine Longworth spoke to CEO Mondher Mahjoubi to find out the science behind this next generation of immunotherapies. . Founded in 1999, Marseille-based company Innate Pharma is on a mission to develop immunotherapies that take advantage of the body’s innate immune system.

article thumbnail

FDA Approves Novel Non-Stimulant Treatment for ADHD

BioSpace

Shares of Supernus Pharmaceuticals were climbing in premarket trading this morning after Friday’s announcement the U.S. FDA approved the company’s non-stimulant treatment for ADHD in pediatric patients 6 to 17 years of age.

article thumbnail

The New Age of Decentralized Clinical Trials

White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations

article thumbnail

Nationwide launch for pioneering fertility study

Pharma Times

The NIHR-funded trial will assess whether removing small fibroids and endometrial polyps improves fertility and live births

Trials 123
article thumbnail

Takeda, CSL to end alliance as plasma-based COVID-19 drug fails key test

Bio Pharma Dive

An unusual partnership to develop a standardized plasma therapy for COVID-19 didn't succeed, but could be a model for collaborations should another public health crisis arise, the drugmakers said.

Drugs 292
article thumbnail

Researchers Are Hatching a Low-Cost Coronavirus Vaccine

NY Times

A new formulation entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic.

article thumbnail

HIV Research is at an Inflection Point, Offering Hope for a Cure

BioSpace

Recent advances are giving researchers hope that a functional cure or possibly even complete eradication of the virus is possible.

Research 115
article thumbnail

How Machine Learning Drives Clinical Trial Efficiency

Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.

article thumbnail

Benefits of AZ vaccine outweigh risks, says MHRA

Pharma Times

The risk of rare blood clots is currently calculated at four people in a million who receive the vaccine

article thumbnail

Lilly claims promising finding in failed study of COVID-19 drug

Bio Pharma Dive

Baricitinib, an oral tablet already authorized to treat COVID-19, fell short of goal in a large Phase 3 study. But Lilly also reported treatment led to a substantial reduction in death.

Drugs 288
article thumbnail

Organizing For The New Normal

Triage Cancer

It's spring. We're starting to emerge from, well, a lot of things. Over the past year, I've heard just about every kind of organizing/decluttering/reordering response to our pandemic isolation and work-from-home shifts. Some folks, stuck in their spaces with less to do than usual and feeling claustrophobic, jumped on the decluttering bandwagon and cleared things out with a vengeance.

article thumbnail

Researchers Are Hatching a Low-Cost Covid-19 Vaccine

NY Times

A new formulation entering clinical trials in Brazil, Mexico, Thailand and Vietnam could change how the world fights the pandemic.

article thumbnail

What the FDA's New Dosage Guidance Means for the Future of Clinical Research

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

article thumbnail

Artios, Novartis form cancer therapies collaboration

Pharma Times

The deal could be worth as much as $1.

108
108
article thumbnail

Ionis cuts jobs at a former spinout and inks new deal with Sobi

Bio Pharma Dive

Some seven months after acquiring the rest of Akcea Therapeutics, Ionis is laying off most of its subsidiary's staff and turning to Sobi to sell its drugs.

Drugs 287
article thumbnail

How COVID-19 Impacted the Food Supply Chain For Better and for Worse

XTalks

Most grocery shoppers won’t soon forget the perplexing moment last spring when shelves were suddenly bare. Where flour, pasta and other shelf-stable goods once sat in abundance quickly emptied to nothing but price tags. The same went for meat and dairy. It was a shocking, yet humbling, sight for most. The news of farmers dumping milk, letting crops rot and euthanizing chickens only added to the disarray.

article thumbnail

COVID-19 News: Clinical Trial for Moderna Booster Begins and More

BioSpace

There continue to be studies and trials related to vaccines and drugs against COVID-19. Here’s a look.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time